GLENMEDE TRUST CO NA - PHARMERICA CORP ownership

PHARMERICA CORP's ticker is PMC and the CUSIP is 71714F104. A total of 1 filers reported holding PHARMERICA CORP in Q4 2008. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of PHARMERICA CORP
ValueSharesWeighting
Q3 2017$4,000
+33.3%
1370.0%0.00%
Q2 2017$3,0000.0%1370.0%0.00%
Q1 2017$3,000
-40.0%
137
-47.3%
0.00%
Q1 2016$5,000
-16.7%
260
+33.3%
0.00%
Q4 2015$6,000
+100.0%
195
+28.3%
0.00%
Q3 2015$3,000
+50.0%
152
+145.2%
0.00%
Q2 2015$2,00062
+14.8%
0.00%
Q4 2010$0540.0%0.00%
Q3 2010$0540.0%0.00%
Q2 2010$0540.0%0.00%
Q1 2010$0540.0%0.00%
Q4 2009$0
-100.0%
540.0%0.00%
Q3 2009$1,0000.0%540.0%0.00%
Q2 2009$1,000540.0%0.00%
Q1 2009$0540.0%0.00%
Q4 2008$0
-100.0%
540.0%0.00%
Q3 2008$1,0000.0%540.0%0.00%
Q2 2008$1,000540.0%0.00%
Q1 2008$0540.0%0.00%
Q3 2007$0540.00%
Other shareholders
PHARMERICA CORP shareholders Q4 2008
NameSharesValueWeighting ↓
Smith, Graham & Co., Investment Advisors, LP 372,169$8,229,0001.08%
LOMBARDIA CAPITAL PARTNERS LLC 839,636$18,564,0000.96%
Malaga Cove Capital, LLC 45,139$998,0000.82%
Endurant Capital Management LP 99,490$2,200,0000.71%
Phocas Financial Corp. 262,430$5,802,0000.45%
Century Capital Management, LLC 154,646$3,419,0000.38%
Personal Capital Advisors Corp 325,099$7,188,0000.33%
FULLER & THALER ASSET MANAGEMENT, INC. 718,292$15,881,0000.31%
ENDICOTT MANAGEMENT CO 30,000$663,0000.23%
Convergence Investment Partners, LLC 70,550$1,560,0000.19%
View complete list of PHARMERICA CORP shareholders